CD40LG and myeloid sarcoma: Other markers that have been shown to have prognostic potential for predicting the conversion of CIS to clinical definite (CD) MS, from RRMS to secondary progressive (SP) MS and a worse disease progression include oligoclonal IgM bands (OCMB) and protein 14-3-3 (39).